BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//EGLCC - ECPv6.14.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.eglcc.eu/fr/
X-WR-CALDESC:Évènements pour EGLCC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260601T160000
DTEND;TZID=Europe/Berlin:20260601T200000
DTSTAMP:20260625T121317
CREATED:20260616T122856Z
LAST-MODIFIED:20260616T122856Z
UID:10496-1780329600-1780344000@www.eglcc.eu
SUMMARY:REDI Biopharma & Health Chapter Launch
DESCRIPTION:REDI launches its Biopharma and Health Chapter\, hosted by MSD España\, marking the first dedicated space for LGBTIQ+ inclusion within the health and biopharmaceutical sector. The initiative aims to promote safe\, respectful\, and inclusive workplaces through concrete\, sector-specific actions.  \nThe session defined key priorities for the alliance\, with contributions from industry leaders including Airbus (through Airbus leadership representation in REDI governance)\, AbbVie\, bioMérieux\, and others across the sector. \nParticipating organizations also included Amavir\, AstraZeneca\, Bristol Myers Squibb\, IVI RMA GLOBAL\, Johnson & Johnson\, Kyowa Kirin\, and Eli Lilly and Company. The sector is now the third most represented within REDI.
URL:https://www.eglcc.eu/fr/event/redi-biopharma-health-chapter-launch/
LOCATION:Oficinas MSD C/ Josefa Valcárcel\, 42 Madrid\, Oficinas MSD C/ Josefa Valcárcel\, 42\, Madrid\, Spain
ORGANIZER;CN="REDI":MAILTO:contacto@redi-lgbti.org
END:VEVENT
END:VCALENDAR